11 Apr Bayh-Dole Coalition: Activist Groups’ Bid for Medicare to Make Generic Xtandi is a ‘Desperate Ploy’
Eileen McDermott
IPWatchdog, 4/11/2024
...
News
10 Apr Bayh-Dole Coalition Statement on Newest Effort to Misuse the Bayh-Dole Act for Price Control
WASHINGTON, D.C. (April 10, 2024) – Several activist groups recently sent a letter to the Centers for Medicare & Medicaid Services (CMS), urging the agency to use its authority under 35 U.S.C. § 202(c)(4) and 28 U.S.C. § 1498 to disregard patent protections...
09 Apr Biden administration urged to license prostate cancer drug patents in a bid to lower its cost
Ed Silverman
STAT, 4/9/2024
...
03 Apr Biden administration patent policy would hurt Wisconsin tech sector
Erik Iverson
Wisconsin State Journal, 4/3/2024...
28 Mar Heralding mRNA and NRTIs — Perspectives on Drug Invention and Development
Brian Gazaille
BioProcess International, 3/27/2024
...
26 Mar Penn and Rutgers warn new federal rules meant to lower drug prices have ‘unintended consequences’
WHYY News, 3/26/2024 ...
20 Mar Kate Hudson & Joseph P. Allen – The Fact Free Attacks on IP
Vital Health Podcast, 3/20/2024 ...
13 Mar Reject Biden’s Overreach on March-In Rights
Robert Taylor
RealClearHealth, 3/13/2024...
11 Mar March-In Drive Loses a Wheel: Generics Industry Says No to Biden Framework
Joseph Allen
IPWatchdog, 3/11/2024...
08 Mar A plan to bring down drug prices could threaten America’s technology boom
Lita Nelsen
MIT Technology Review, 3/8/2024...